Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
) Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
25.11.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ) Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy. |
---|---|
Bibliography: | Application Number: AU20200213282 |